Levosimendan protects human hepatocytes from ischemia-reperfusion injury.

about

Levosimendan protects human hepatocytes from ischemia-reperfusion injury.

Item

http://www.wikidata.org/entity/Q44783201

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Levosimendan protects human hepatocytes from ischemia-reperfusion injury.

@en

Levosimendan protects human hepatocytes from ischemia-reperfusion injury.

@nl

type

Item

label

Levosimendan protects human hepatocytes from ischemia-reperfusion injury.

@en

Levosimendan protects human hepatocytes from ischemia-reperfusion injury.

@nl

prefLabel

Levosimendan protects human hepatocytes from ischemia-reperfusion injury.

@en

Levosimendan protects human hepatocytes from ischemia-reperfusion injury.

@nl

P1476

Levosimendan protects human hepatocytes from ischemia-reperfusion injury

@en

P2093

Andreas A Schnitzbauer

http://www.w3.org/2001/XMLSchema#string

Andres Beiras-Fernandez

http://www.w3.org/2001/XMLSchema#string

Anton Moritz

http://www.w3.org/2001/XMLSchema#string

Eva Juengel

http://www.w3.org/2001/XMLSchema#string

Isabella Werner

http://www.w3.org/2001/XMLSchema#string

Nicolai V Bogert

http://www.w3.org/2001/XMLSchema#string

Stefanie N Brunner

http://www.w3.org/2001/XMLSchema#string

P2860

Regulated necrotic cell death: the passive aggressive side of Bax and Bak

Levosimendan: a cardiovascular drug to prevent liver ischemia-reperfusion injury?

The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions.

Pulmonary ischaemia-reperfusion injury: role of apoptosis.

Mitochondria and ischemia/reperfusion injury.

Gene therapy in liver ischemia and reperfusion injury.

Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion.

The biologic characteristics of cytokines and their implication in surgical injury.

Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.

Levosimendan modulates programmed forms of cell death through K(ATP) channels and nitric oxide.

P304

e0187839

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0187839

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Angela Kornberger

P577

2017-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29145424

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury

P932

5690693

http://www.w3.org/2001/XMLSchema#string